FRANKFURT, April 21 (Reuters) - AstraZeneca's CEO told daily Handelsblatt on Tuesday that Germany risks missing out on new ...

Speaking to German newspaper Handelsblatt, CEO Pascal Soriot said proposed cost-cutting measures in the country’s healthcare ...

AstraZeneca's CEO warns that Germany might miss out on new drug launches if it continues its plans to limit pharmaceutical spending. Proposed regulations might hinder drug introductions, affecting ...

Use of the AstraZeneca COVID-19 vaccine was suspended again Tuesday in Germany for people under 60 years old after a series of patients reported experiencing blood clots. Authorities say 31 people — ...